You're Reacting to Everything Around You. Your Genes May Be Why.

GSTM1 encodes one of your body’s primary Phase II detoxification enzymes. Phase II is where your cells conjugate (bind) environmental toxins, heavy metals, and carcinogens to glutathione, making them water-soluble so they can be excreted. Without GSTM1, this conjugation step for an entire class of compounds simply doesn’t happen.

The issue: approximately 50% of people are born with a complete deletion of the GSTM1 gene. They have zero functional GSTM1 enzyme. Their cells have lost one of their primary tools for detoxifying a broad spectrum of environmental chemicals. That doesn’t mean they get sick from every exposure. It means their detox capacity is reduced from day one. Add a moldy environment, chronic low-level pesticide exposure, or occupational chemical contact, and their burden exceeds their capacity.

In practical terms, you likely notice you’re more sensitive to paint fumes, new car smell, cleaning products, and mold than people around you. You recover slowly from environmental exposures. Stepping into a water-damaged building leaves you foggy and exhausted while your coworkers feel nothing.

GSTP1 is another key Phase II detox enzyme, and it’s present in virtually everyone (unlike GSTM1, which is deleted in half the population). The issue with GSTP1 is not deletion but reduced activity. The Ile105Val variant, carried by roughly 35-40% of people, reduces how efficiently your enzyme conjugates reactive electrophiles and oxidative stress byproducts.

When you’re exposed to mold, volatile organic compounds, or air pollution, your cells produce reactive oxygen species and electrophilic compounds as a byproduct of detoxification itself. Your GSTP1 enzyme is supposed to neutralize these dangerous intermediates. If your GSTP1 variant reduces enzyme activity by 30-50%, those reactive compounds linger longer in your cells, causing mitochondrial damage and triggering inflammatory signaling. You don’t just fail to clear the toxin; you amplify the immune signal because your antioxidant systems are overwhelmed.

You probably notice that your CIRS symptoms worsen in spring (higher mold spore counts) or after chemical exposures like pesticide spray. You recover slowly even after removing the exposure. Your fatigue feels deep, cellular, and not relieved by rest.

GSTT1, like GSTM1, can be completely deleted. Roughly 15-20% of people with European ancestry carry the GSTT1 null variant. GSTT1 specializes in conjugating volatile organic compounds, certain pesticides, and disinfection byproducts like trihalomethanes that are present in treated water.

If you have the null variant, your cells cannot effectively clear these specific chemical classes. When you shower or drink chlorinated water, your body cannot efficiently detoxify the disinfection byproducts. If you’re in a moldy building that was treated with fungicides, your GSTT1 system can’t handle that chemical load. You develop symptoms not from the mold itself, but from your inability to clear the fungicide or disinfectant used to treat it. This is a commonly missed piece of CIRS. People avoid moldy buildings, but if those buildings were heavily treated with antimicrobials, the byproducts are still in the air and water.

Your practical experience: you feel worse after showers or being in freshly cleaned spaces. You’re sensitive to the smell of cleaning products, paint, or pesticides. You recover poorly from environmental exposures because the chemicals your friends’ GSTT1 enzymes clear in hours linger in your cells for days.

MTHFR is famous (and often overhyped), but in the context of CIRS, it plays a critical role that’s frequently overlooked. MTHFR converts dietary folate into a form your cells use for methylation reactions. One of those reactions is the synthesis of glutathione, your most important cellular antioxidant. Without adequate methylation, glutathione production drops.

The C677T variant, carried by approximately 40% of European populations, reduces MTHFR enzyme activity by 35-70%. If you’re homozygous (two copies), the reduction is even more pronounced. Your cells cannot efficiently convert B vitamins into the methylated forms they need. The result is lower glutathione production at precisely the moment your body needs more glutathione to clear environmental toxins. You’re simultaneously more sensitive to toxins and less able to neutralize them.

You likely experience brain fog, difficulty concentrating, and mood instability in addition to your CIRS symptoms. You feel worse in winter or when your stress is high (both increase methylation demand). You may notice you’re sensitive to supplemental folic acid but feel better on methylated folate.

SOD2 is your mitochondria’s primary antioxidant enzyme. It neutralizes superoxide radicals before they damage mitochondrial DNA and proteins. When you’re exposed to environmental toxins, air pollution, or mold, your mitochondria are the first to bear the burden. They’re working overtime to detoxify and produce energy simultaneously. Without adequate SOD2 activity, they accumulate damage.

The Val16Ala variant, present in roughly 40% of European populations as the homozygous variant, reduces SOD2 activity and mitochondrial protective capacity. The result is not a sudden energy crash but a creeping fatigue that accumulates over days of environmental exposure. Your mitochondria are becoming progressively damaged, and your cells cannot produce energy efficiently even at rest. You feel it as cellular exhaustion, not just tiredness. You may also experience post-exertional malaise, where physical activity leaves you wiped out for days.

Your pattern: you might have good energy for a few hours, then hit a wall. You’re sensitive to exertion when your environmental burden is high. You recover poorly from infections or stressful periods. Your fatigue has a metabolic quality to it, not an emotional one.

TNF is an inflammatory cytokine, a chemical messenger that tells your immune system to mount an inflammatory response. Everyone produces TNF, but your genetic variant determines how much. The -308G>A polymorphism, carried by roughly 30% of people, increases TNF production in response to threats.

This is where the immune part of CIRS becomes relevant. You don’t have an autoimmune disease (your immune system isn’t attacking your own tissues). But you do have a genetic predisposition to mount a larger inflammatory response when exposed to mold or other environmental triggers. Your immune system sees the mycotoxins or volatile organics and signals your body that the threat level is high. Your body responds with fatigue (to conserve energy), fever-like symptoms, joint pain, and cognitive fog. If your TNF variant predisposes you to higher baseline production, even a small environmental exposure can trigger a disproportionate inflammatory cascade. This is partly why your friends exposed to the same mold show no symptoms while you’re devastated.

Your experience: mold or chemical exposures trigger flu-like symptoms, not allergic symptoms. You develop joint pain, body aches, and brain fog rather than sneezing or itchy eyes. Your symptoms follow the pattern of systemic inflammation, not local allergic reaction.